![EMJ Dermatology 9 [Supplement 1] 2021 Front Cover](https://emj.emg-health.com/wp-content/uploads/sites/2/2020/12/EMJ-Dermatology-9-Supplement-1-2021-Front-Cover.jpg)
At the 2020 European Academy of Dermatology and Venerology (EADV) Virtual Congress, data for 5-year efficacy and safety of tildrakizumab in adults with moderate-to-severe plaque psoriasis were presented across six posters. Overall, it was shown that tildrakizumab has a very favourable long-term efficacy and safety profile.
Latest articles
All articles
6 Mins
28
Apr
Case Report of Epstein–Barr Virus-Induced Autoimmune Vitiligo in Nigeria
Vitiligo is an acquired skin depigmenting disorder resulting from melanocytes loss in the epidermis, associated with an autoimmune aetiopathophysiology. However, there are limited data about the association between vitiligo and Epstein–Barr virus (EBV).
